111 related articles for article (PubMed ID: 9014240)
1. Modeling and mutagenesis of the human alpha 1a-adrenoceptor: orientation and function of transmembrane helix V sidechains.
Wetzel JM; Salon JA; Tamm JA; Forray C; Craig D; Nakanishi H; Cui W; Vaysse PJ; Chiu G; Weinshank RL; Hartig PR; Branchek TA; Gluchowski C
Recept Channels; 1996; 4(3):165-77. PubMed ID: 9014240
[TBL] [Abstract][Full Text] [Related]
2. Amino acids of the human alpha1d-adrenergic receptor involved in antagonist binding.
Nagaoka Y; Ahmed M; Hossain M; Bhuiyan MA; Ishiguro M; Nakamura T; Watanabe M; Nagatomo T
J Pharmacol Sci; 2008 Jan; 106(1):114-20. PubMed ID: 18187928
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay.
Ahmed M; Hossain M; Bhuiyan MA; Ishiguro M; Tanaka T; Muramatsu I; Nagatomo T
Biol Pharm Bull; 2008 Apr; 31(4):598-601. PubMed ID: 18379048
[TBL] [Abstract][Full Text] [Related]
4. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
Zhao MM; Hwa J; Perez DM
Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
[TBL] [Abstract][Full Text] [Related]
5. Addition of a signal peptide sequence to the alpha1D-adrenoceptor gene increases the density of receptors, as determined by [3H]-prazosin binding in the membranes.
Petrovska R; Kapa I; Klovins J; Schiöth HB; Uhlén S
Br J Pharmacol; 2005 Mar; 144(5):651-9. PubMed ID: 15678090
[TBL] [Abstract][Full Text] [Related]
6. Extracellular surface residues of the α1B-adrenoceptor critical for G protein-coupled receptor function.
Ragnarsson L; Andersson Å; Thomas WG; Lewis RJ
Mol Pharmacol; 2015 Jan; 87(1):121-9. PubMed ID: 25352041
[TBL] [Abstract][Full Text] [Related]
7. Novel aromatic residues in transmembrane domains IV and V involved in agonist binding at alpha(1a)-adrenergic receptors.
Waugh DJ; Zhao MM; Zuscik MJ; Perez DM
J Biol Chem; 2000 Apr; 275(16):11698-705. PubMed ID: 10766790
[TBL] [Abstract][Full Text] [Related]
8. Novel human alpha1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function.
Lei B; Morris DP; Smith MP; Svetkey LP; Newman MF; Rotter JI; Buchanan TA; Beckstrom-Sternberg SM; Green ED; Schwinn DA
Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):229-39. PubMed ID: 15900517
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
[TBL] [Abstract][Full Text] [Related]
10. Modelling the interaction of catecholamines with the alpha 1A adrenoceptor towards a ligand-induced receptor structure.
Kinsella GK; Rozas I; Watson GW
J Comput Aided Mol Des; 2005 Jun; 19(6):357-67. PubMed ID: 16231197
[TBL] [Abstract][Full Text] [Related]
11. Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors.
Cogé F; Guenin SP; Renouard-Try A; Rique H; Ouvry C; Fabry N; Beauverger P; Nicolas JP; Galizzi JP; Boutin JA; Canet E
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):231-9. PubMed ID: 10493934
[TBL] [Abstract][Full Text] [Related]
12. Conopeptide ρ-TIA defines a new allosteric site on the extracellular surface of the α1B-adrenoceptor.
Ragnarsson L; Wang CI; Andersson Å; Fajarningsih D; Monks T; Brust A; Rosengren KJ; Lewis RJ
J Biol Chem; 2013 Jan; 288(3):1814-27. PubMed ID: 23184947
[TBL] [Abstract][Full Text] [Related]
13. Agonist-specific coupling of a cloned human alpha1A-adrenoceptor to different second messenger pathways.
Richardson J; Chatwin H; Hirasawa A; Tsujimoto G; Evans PD
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):333-41. PubMed ID: 12690424
[TBL] [Abstract][Full Text] [Related]
14. Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships.
De Benedetti PG; Fanelli F; Menziani MC; Cocchi M; Testa R; Leonardi A
Bioorg Med Chem; 1997 May; 5(5):809-16. PubMed ID: 9208092
[TBL] [Abstract][Full Text] [Related]
15. Asp125 and Thr130 in transmembrane domain 3 are major sites of alpha1b-adrenergic receptor antagonist binding.
Takahashi K; Hossain M; Ahmed M; Bhuiyan MA; Ohnuki T; Nagatomo T
Biol Pharm Bull; 2007 Oct; 30(10):1891-4. PubMed ID: 17917257
[TBL] [Abstract][Full Text] [Related]
16. Phe(303) in TMVI of the alpha(1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation.
Chen S; Lin F; Xu M; Graham RM
Biochemistry; 2002 Jan; 41(2):588-96. PubMed ID: 11781098
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-adrenergic receptor subtype determinants for 4-piperidyl oxazole antagonists.
Hamaguchi N; True TA; Goetz AS; Stouffer MJ; Lybrand TP; Jeffs PW
Biochemistry; 1998 Apr; 37(16):5730-7. PubMed ID: 9548959
[TBL] [Abstract][Full Text] [Related]
18. Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout.
Muramatsu I; Morishima S; Suzuki F; Yoshiki H; Anisuzzaman AS; Tanaka T; Rodrigo MC; Myagmar BE; Simpson PC
Br J Pharmacol; 2008 Dec; 155(8):1224-34. PubMed ID: 18806813
[TBL] [Abstract][Full Text] [Related]
19. Binding site analysis of full-length alpha1a adrenergic receptor using homology modeling and molecular docking.
Pedretti A; Elena Silva M; Villa L; Vistoli G
Biochem Biophys Res Commun; 2004 Jun; 319(2):493-500. PubMed ID: 15178433
[TBL] [Abstract][Full Text] [Related]
20. The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling.
Stitham J; Stojanovic A; Merenick BL; O'Hara KA; Hwa J
J Biol Chem; 2003 Feb; 278(6):4250-7. PubMed ID: 12446735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
